Inceptua Pharma

We market and commercialize specialty care and rare disease  products 

We have a proven track record and expertise in Commercial, Medical and Patient Access

Inceptua has a very experienced commercialization team, with a patient centric approach. Our core competence is to successfully bring specialty, rare disease, and orphan drugs to the market. Our team puts equal focus on commercial, medical and market access, securing the holistic approach needed to succeed.  We have a strong infrastructure, local presence, and expertise covering Europe and the Middle East.

circles

Commercial

Medical

Patient access

Partnering

Inceptua in-license or partner late stage assets or commercial stage products. Our partnership models are flexible and the structure depends on the strategic objectives of our partners.

Products

Jetrea® (ocriplasmin)

Jetrea is a truncated form of human plasmin and is a first-in-class pharmacological vitreolysis therapy approved to treat patients with symptomatic vitreomacular adhesion or vitreomacular traction.

Farydak® (panobinostat)

Farydak (panobinostat) is a prescription oral medication used in combination with proteasome inhibitors and corticosteroids to treat patients with relapsed or refractory multiple myeloma who have received prior treatments.

Apelea® (paclitaxel micellar)

Click on 'Read More' below to access the press release: Elevar Therapeutics Inc. Announces Licensing Agreement with Inceptua Group for Commercialization of Apealea® (Paclitaxel Micellar) in Europe

With a highly experienced team and full commercialization
capabilities we tailor partnerships to meet our partners
mid and long term objectives

Our team is engaged, entrepreneurial, and patient centric, with a long track record bringing products to the market. With our significant experience of different partnership models, we are open for traditional in-licensing as well as flexible distribution set-ups. Our adaptable approach allows us to work with tailored partnership solutions that best support the needs of our partners and their mid- to long-term objectives.

Any questions?

Ask our experts

About

Clive leads Inceptua Pharma and has extensive experience in developing access and pricing approaches for specialty and rare disease therapies.

Clive Whitcher

EXECUTIVE VICE PRESIDENT
HEAD OF PHARMA

About

With a solid pharmaceutical industry background in marketing, sales, and corporate development, Stefan leads the Inceptua Group.

Stefan Fraenkel

CHIEF EXECUTIVE OFFICER
INCEPTUA GROUP

About

With a background in practicing medicine, Maria oversees all activity to ensure that patient safety remains at the core of our operations.

Maria Eklind

CHIEF MEDICAL OFFICER
INCEPTUA GROUP

About

Industry expert Annika leads our global supply chain and operations, and ensures best-in-class supply chain solutions for our clients.

Annika Kollén

EXECUTIVE VICE PRESIDENT
GLOBAL SUPPLY CHAIN AND OPERATIONS

About

25 years of experience in a range of roles in pharma. Jeremy leads the business development of Inceptua Pharma.

Jeremy Broadis

CHIEF BUSINESS OFFICER
BUSINESS DEVELOPMENT, INCEPTUA PHARMA

We support the
biopharmaceutical industry
in extending the reach of
their treatments to help
patients in need.

Early Access

Clinical Trial Supply

We use cookies to give you the best experience.